Tech Company Financing Transactions
SEngine Precision Medicine Funding Round
SEngine Precision Medicine, operating out of Seattle, secured $5.1 million from Bangarang and private investors.
Transaction Overview
Company Name
Announced On
10/3/2019
Transaction Type
Venture Equity
Amount
$5,100,000
Round
Series A
Investors
Bangarang (Lead Investor) (Elliott Burkland)
Proceeds Purpose
This round of financing positions us to move quickly to both commercialize and scale our technology
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
401 Terry Ave. N.
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Not Recorded
Overview
SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine's high-throughput technology simultaneously tests more than 100 cancer drugs against a patient's unique tumor organoid outside the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carla Grandori
Browse more venture capital transactions:
Prev: 10/3/2019: LEX Markets venture capital transaction
Next: 10/3/2019: Spineology venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs